Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Quantitative podocyte parameters predict human native kidney and allograft half-lives
Abhijit S. Naik, … , Yi Li, Roger C. Wiggins
Abhijit S. Naik, … , Yi Li, Roger C. Wiggins
Published May 19, 2016
Citation Information: JCI Insight. 2016;1(7):e86943. https://doi.org/10.1172/jci.insight.86943.
View: Text | PDF
Clinical Medicine Aging Nephrology

Quantitative podocyte parameters predict human native kidney and allograft half-lives

  • Text
  • PDF
Abstract

BACKGROUND. Kidney function decreases with age. A potential mechanistic explanation for kidney and allograft half-life has evolved through the realization that linear reduction in glomerular podocyte density could drive progressive glomerulosclerosis to impact both native kidney and allograft half-lives.

METHODS. Predictions from podometrics (quantitation of podocyte parameters) were tested using independent pathologic, functional, and outcome data for native kidneys and allografts derived from published reports and large registries.

RESULTS. With age, native kidneys exponentially develop glomerulosclerosis, reduced renal function, and end-stage kidney disease, projecting a finite average kidney life span. The slope of allograft failure rate versus age parallels that of reduction in podocyte density versus age. Quantitative modeling projects allograft half-life at any donor age, and rate of podocyte detachment parallels the observed allograft loss rate.

CONCLUSION. Native kidneys are designed to have a limited average life span of about 100–140 years. Allografts undergo an accelerated aging-like process that accounts for their unexpectedly short half-life (about 15 years), the observation that older donor age is associated with shorter allograft half-life, and the fact that long-term allograft survival has not substantially improved. Podometrics provides potential readouts for these processes, thereby offering new approaches for monitoring and intervention.

FUNDING: National Institutes of Health.

Authors

Abhijit S. Naik, Farsad Afshinnia, Diane Cibrik, Jeffrey B. Hodgin, Fan Wu, Min Zhang, Masao Kikuchi, Larysa Wickman, Milagros Samaniego, Markus Bitzer, Jocelyn E. Wiggins, Akinlolu Ojo, Yi Li, Roger C. Wiggins

×

Figure 6

Donor age in relation to allograft half-life plots.

Options: View larger image (or click on image) Download as PowerPoint
Donor age in relation to allograft half-life plots.
(A) Donor age versus...
(A) Donor age versus allograft half-life. Deceased donor allograft half-life is plotted on the x axis and kidney age on the y axis from data shown in Table 1. Donor kidney age is linearly related to allograft half-life over all donor ages from 20 to 80 years (P < 0.001 for aggregated data, n = 122,803; linear regression model). The slope coordinates can be interpreted to show that the allograft aging rate is 5.6-fold faster than the donor aging rate, and that had the kidney not been transplanted (half-life = 0 years), its expected life span would have been about 121 years. (B) “Biologic” versus “chronologic” kidney aging. Donor age is plotted on the x axis and total kidney age (either chronologic or biologic) on the y axis. The triangles represent the kidney age at time of donation. The circles show the average total chronologic kidney age at which the allograft will fail for various donor ages (estimated as the kidney age at donation + the chronologic allograft half-life). The squares show the total biologic kidney age at which the kidney will fail (estimated as the kidney age at donation + the allograft half-life × 5.6 to account for accelerated allograft biologic aging). Thus, all allografts, whatever their donor age, will on average fail when their total biologic age (donor age + allograft age × 5.6) = 121 years. The difference between the squares and the circles at any donor age represents the lost allograft function due to the accelerated aging-like process experienced by allografts that could be targeted therapeutically. Data are from the OPTN/UNOS database as of September 5,2014 (25).

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts